9 completed, 3 unknown, 2 terminated, 1 not yet recruiting. 16 Phase 1, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 16 | Completed 9, Unknown 3, Terminated 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 10 | Completed 6, Unknown 2, Not yet recruiting 1, Withdrawn 1 |
Follow Pentoxifylline: new trials by email Literature Review of Pentoxifylline trials Research Report on Pentoxifylline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pentoxifylline for Vascular Calcification in Kidney Disease Pentoxifylline 400 MG Oral Tablet, Conventional Medications for Chronic Kidney Disease - Chronic Kidney Disease, Vascular Calcification | Phase 1 / Phase 2 | Not yet recruiting | Mansoura University | 80 | 2025-04-15 | 2025-04-01 |
| Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial Metformin Hydrochloride, betamethasone dipropionate, Pentoxifylline - Oral Submucous Fibrosis | Phase 1 / Phase 2 | Completed | Ziauddin University | 30 | 2024-08-12 | 2025-05-02 |
| Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke Pentoxifylline - Cognitive Impairment | Phase 1 / Phase 2 | Unknown | The First Hospital of Hebei Medical University | 200 | 2024-04-10 | 2024-04-03 |
| Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata. Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin - Alopecia Areata | Phase 1 | Unknown | Assiut University | 60 | 2023-10-01 | 2023-10-18 |
| Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients Pentoxifylline, Placebo - COVID | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2022-11-13 | 2023-01-18 | |
| Pentoxifylline for Treatment of Resistant Major Depression Pentoxifylline, Placebo - Resistant Major Depression | Phase 1 / Phase 2 | Completed | Hawler Medical University | 60 | 2021-12-15 | 2022-09-07 |
| Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet) - Major Depressive Disorder | Phase 1 / Phase 2 | Completed | Hawler Medical University | 100 | 2021-11-10 | 2022-09-07 |
| Pentoxifylline Add-on Therapy for Schizophrenia Oxopurin - Schizophrenia | Phase 1 / Phase 2 | Unknown | Mazra Mental Health Center | 90 | 2019-04-20 | 2021-10-11 |
| Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia Placebo oral tablet, Pentoxifylline - Schizophrenia | Phase 1 / Phase 2 | Completed | Sadat City University | 80 | 2019-01-01 | 2022-10-25 |
| Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to TrentalĀ® Administered to Healthy Subjects PCS499, Trental - Healthy | Phase 1 | Completed | Processa Pharmaceuticals | 18 | 2018-02-26 | 2019-02-12 |
| Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy Pentoxifylline - Muscular Dystrophy, Duchenne | Phase 1 / Phase 2 | Completed | Cooperative International Neuromuscular Research Group | 64 | 2005-09-01 | 2011-10-27 |
| Pentoxifylline for Acute Alcoholic Hepatitis (AAH) pentoxifylline - Hepatitis, Alcoholic | Phase 1 | Terminated | University of Wisconsin, Madison | 4 | 2005-03-01 | 2014-05-13 |
| Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome pentoxifylline - Hepatopulmonary Syndrome | Phase 1 | Terminated | University of Alabama at Birmingham | 9 | 2004-06-01 | 2015-03-09 |
| Pentoxifylline in Duchenne Muscular Dystrophy Pentoxifylline - Muscular Dystrophy, Duchenne | Phase 1 / Phase 2 | Completed | Cooperative International Neuromuscular Research Group | 17 | 2002-03-01 | 2011-10-27 |
| Radiation Therapy in Treating Patients With Glioblastoma chemotherapy, hydroxyurea, pentoxifylline - Brain and Central Nervous System Tumors | Phase 1 | Completed | National Cancer Institute (NCI) | 34 | 1995-04-01 | 2015-04-29 |
| Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS Pentoxifylline - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 54 | 2021-11-02 |
Muscular Dystrophy, Duchenne (2) · Schizophrenia (2) · Acquired Immunodeficiency Syndrome (1) · Alopecia Areata (1) · Bipolar Disorder (1) · Cachexia (1) · Camurati-Engelmann Syndrome (1) · Central Nervous System Neoplasms (1) · Cognitive Dysfunction (1) · Depressive Disorder, Major (1) · Fibrosis (1) · Glioblastoma (1) · Gliosarcoma (1) · HIV Infections (1) · Hepatitis, Alcoholic (1)
Cooperative International Neuromuscular Research Group (2) · Hawler Medical University (2) · Sadat City University (2) · Assiut University (1) · Mansoura University (1) · Mazra Mental Health Center (1) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Processa Pharmaceuticals (1) · The First Hospital of Hebei Medical University (1) · University of Alabama at Birmingham (1) · University of Wisconsin, Madison (1) · Ziauddin University (1)
United States (5) · Egypt (3) · Iraq (2) · Israel (2) · Argentina (1) · Australia (1) · Canada (1) · China (1) · Italy (1) · Pakistan (1) · United Kingdom (1)
Diana Escolar, MD (2) · Talar A Merzamohammad, Pharm. D (2) · Brian G. Fuller, MD (1) · Crumpacker C (1) · Dezube B (1) · Jiaying Rong, master (1) · Michael B Fallon, MD (1) · Michael R Lucey, MD (1) · Nada K. Mostafa, bachelor (1) · Sharan Sidhu, MBChB (1)
PMID 18668653, PMID 28390753, PMID 30302901, PMID 31472446, PMID 33008091, PMID 34007848, PMID 35410255, PMID 36341700, PMID 36552855
R03DK065958 (1)